ACTIVE

PHARMACIE SENEFFE CENTRE

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result215,7 k €-16,6 %over 1 year
Gross margin576,9 k €-13,5 %over 1 year
Equity586,4 k €-46,2 %over 1 year
Workforce4,0 ETP-13,0 %over 1 year

Identity

Source · BCE/KBO

PHARMACIE SENEFFE CENTRE is a Private limited company incorporated in 2002. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Seneffe. It employs on average 4,0 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0477.710.053
Incorporation
07/06/2002
Legal form
Private limited company
Registered office
Rue des Canadiens 24
7180 Seneffe · WallonieSee on map
Contributed capital
55 750,00 €
Latest accounts
31/12/2025
Average workforce
4,0 ETP
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

20252024202320222021
Income statement
Gross margin576,9 k €667,3 k €655,4 k €666,6 k €508,3 k €
EBITDA337,7 k €384,1 k €344 k €367,3 k €289,9 k €
Operating result298,9 k €343,9 k €296,6 k €309,8 k €232,3 k €
Net result215,7 k €258,7 k €219,7 k €244,1 k €174,4 k €
Balance sheet
Equity586,4 k €1,1 M €832 k €812,4 k €738,3 k €
Total assets1,5 M €1,5 M €1,5 M €1,4 M €1,2 M €
Cash888,1 k €650,7 k €565,7 k €536,8 k €329,7 k €
Debts884,3 k €372 k €653,2 k €618,1 k €511,4 k €
Other
Workforce4,0 ETP4,6 ETP4,8 ETP4,9 ETP4,4 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 2 ended

Active mandates

DEVANTHINIC PHARMA

Director · since 30 septembre 2017 · 0506.893.294

Represented by Thibaut DE VRIESE

Active

Ended mandates

DEVANTHINIC PHARMA

Manager · since 30 septembre 2017 · 0506.893.294

Represented by THIBAUT DE VRIESE

Ended
ISABELLE DARDENNE

Manager

Ended

Other companies at this address

Rue des Canadiens 24 7180 Seneffe
CompanyCBE no.
DEVANTHINIC IMMO● Active
1039.753.688
DEVANTHINIC PHARMA● Active
0506.893.294
MARIEC.C-PHARMA● Active
0507.640.788
PHAMALIMO● Active
0846.675.386
PHARMACIE ANNE ANDRE● Active
0478.484.667
PHARMACIE DE BASCOUP● Active
0458.492.472
PHARMACIE DE BOIS-D'HAINE● Active
0432.058.190
PHARMACIE DE LA DRÊVE● Active
0421.582.883
PHARMACIE DE LA GRAND RUE● Active
0846.815.047
PHARMACIE DE LA VILLE BASSE● Active
0872.063.652
PHARMA-LOUVE● Active
0894.160.549

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date24/08/202625/08/202526/08/202431/07/202326/08/202227/08/2021
General meeting31/07/202631/07/202531/07/202430/06/202302/06/202203/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202531/07/202624/08/2026FrenchPDF
Abridged model31/12/202431/07/202525/08/2025FrenchPDF
Abridged model31/12/202331/07/202426/08/2024FrenchPDF
Abridged model31/12/202230/06/202331/07/2023FrenchPDF
Abridged model31/12/202102/06/202226/08/2022FrenchPDF
Abridged model31/12/202003/06/202127/08/2021FrenchPDF
Abridged model31/12/201904/06/202005/10/2020FrenchPDF
Abridged model31/12/201806/06/201906/09/2019FrenchPDF
Abridged model31/12/201707/06/201802/08/2018FrenchPDF
Abridged model31/12/201601/06/201715/06/2017FrenchPDF
Abridged model31/12/201529/06/201611/07/2016FrenchPDF
Abridged model31/12/201430/06/201515/07/2015FrenchPDF
Abridged model31/12/201330/06/201425/07/2014FrenchPDF
Abridged model31/12/201230/06/201311/07/2013FrenchPDF
Abridged model31/12/201118/06/201218/07/2012FrenchPDF
Abridged model31/12/201016/06/201114/07/2011FrenchPDF
Abridged model31/12/200919/06/201022/06/2010FrenchPDF
Abridged model31/12/200819/06/200910/07/2009FrenchPDF
Abridged model31/12/200727/06/200815/07/2008FrenchPDF
Abridged model31/12/200629/06/200729/08/2007FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 2 ended

Active mandates

DEVANTHINIC PHARMA

Director · since 30 septembre 2017 · 0506.893.294

Represented by Thibaut DE VRIESE

Active

Ended mandates

DEVANTHINIC PHARMA

Manager · since 30 septembre 2017 · 0506.893.294

Represented by THIBAUT DE VRIESE

Ended
ISABELLE DARDENNE

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates09/09/2022
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE
    PDF
  • Registered office17/12/2018
    SIEGE SOCIAL
    PDF
  • Mandates20/10/2017
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates17/07/2017
    DENOMINATION - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates24/05/2017
    DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates03/11/2014
    DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025215,7 k €↓
  2. 2024
    Annual accounts 2024258,7 k €↑
  3. 2023
    Annual accounts 2023219,7 k €↓
  4. 2022
    Annual accounts 2022244,1 k €↑
  5. 2021
    Annual accounts 2021174,4 k €↑
  6. 2020
    Annual accounts 2020154,8 k €↓
  7. 2019
    Annual accounts 2019304 k €↑
  8. 2018
    Annual accounts 201838,2 k €↑
  9. 2017
    Annual accounts 2017-1,8 k €↓
  10. 2016
    Annual accounts 201631,4 k €↓
  11. 2015
    Annual accounts 201541,5 k €↑
  12. 2014
    Annual accounts 201417,6 k €↓
  13. 2013
    Annual accounts 201331,1 k €↑
  14. 2012
    Annual accounts 201229,7 k €↓
  15. 2011
    Annual accounts 201150,6 k €↑
  16. 2010
    Annual accounts 201032,3 k €↓
  17. 2009
    Annual accounts 200937,3 k €↑
  18. 2008
    Annual accounts 200830,6 k €↑
  19. 2007
    Annual accounts 200713 k €↑
  20. 2006
    Annual accounts 20064,8 k €
  21. 07/06/2002
    IncorporationPrivate limited company